Nick Ertl > Elkington + Fife LLP > Sevenoaks, England > Lawyer Profile

Elkington + Fife LLP
Nick Ertl photo

Work Department

UK and European patent attorney




Nick has 20 years experience in the drafting of patent applications and their prosecution around the world, especially before the EPO. He is entrusted by numerous large multinational corporations to prepare patent applications in the fields of semiconductor electronics, general electronics hardware, optical components and systems. Nick is always excited to work in areas of technology new to him, and to invest his own time to become familiar with the underlying science involved. As a result, he has worked in many diverse areas of technology over the years. Specialist technical fields include: audio-visual technology; communications; electrical devices and electronics; mechanical engineering; semiconductors. Areas of expertise include: filing and prosecution; freedom to operate opinions; patent drafting; validity and infringement opinions.


English, French


University of Nottingham (M.Eng).

Lawyer Rankings

London > TMT (technology, media and telecoms) > PATMA: Patent attorneys

Elkington + Fife LLP is particularly visible in EPO oppositions and appeal proceedings where the team continues to be exceptionally successful, especially in proceedings for pharma clients. The firm enjoys a very good reputation for its life sciences and pharmaceutical patent prosecution work, in particular as advisor to major generics companies and its strong biotechnology track record, but also offers a very experienced electronics practice that distinguishes itself through its original application drafting capabilities. The firm’s ability to attract complex semiconductor, consumer product, materials, and robotics work is also notable. Richard Gillard in London is the head of the chemistry and life sciences group and Nick Ertl in Sevenoaks directs the electrical and mechanical group. Physics and engineering specialist Ellie Seymour in the Sevenoaks office made partner in 2021. In July 2021 Jens Grabenstein, formerly a senior associate at Carpmaels & Ransford LLP and a biotechnology and pharma expert, joined the team.